A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at Stanford.

被引：0
|
作者：
Pumpalova, Yoanna S.
Kozak, Margaret M.
von Eyben, Rie
Fisher, George A.
Kunz, Pamela L.
Chang, Daniel Tandel
Haraldsdottir, Sigurdis
机构：
[1] Stanford Univ, Palo Alto, CA USA
[2] Stanford Univ, Med Ctr, Stanford, CA USA
[3] Stanford Univ, Sch Med, Stanford, CA USA
[4] Stanford Univ, Stanford, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
710
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at a single institution.
    Pumpalova, Yoanna S.
    Kozak, Margaret M.
    von Eyben, Rie
    Kunz, Pamela L.
    Fisher, George A.
    Chang, Daniel Tandel
    Haraldsdottir, Sigurdis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Comparison of definitive chemoradiation with 5-fluorouracil versus capecitabine in anal cancer
    Pumpalova, Yoanna
    Kozak, Margaret M.
    von Eyben, Rie
    Kunz, Pamela
    Fisher, George
    Chang, Daniel T.
    Haraldsdottir, Sigurdis
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (04) : 605 - 615
  • [3] Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer
    Yu, Irene S.
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.
    Yu, Irene
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] CHEMORADIOTHERAPY WITH 5-FU VERSUS CAPECITABINE ON RECTAL CANCER DOWNSTAGING
    Aguas, L.
    Salgado, M.
    Davila, C.
    Costa, A. S.
    Almeida, D.
    Barbosa, M.
    Caeiro, C.
    Sarmento, C.
    Marques, M.
    Damasceno, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 211 - 211
  • [6] Postoperative adjuvant 5-FU/cisplatin and chemoradiation with capecitabine for advanced gastric cancer
    Lee, H.
    Choi, Y.
    Hur, W.
    Kown, H.
    Kim, M.
    Jung, G.
    Choi, H-J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S526 - S526
  • [7] Cost analysis of capecitabine versus 5-FU/LV for colorectal cancer patients in the Netherlands
    Postma, MJ
    van Hartskamp, D
    Jansman, FG
    Willemse, PH
    Brouwers, JR
    [J]. VALUE IN HEALTH, 2002, 5 (06) : 540 - 540
  • [8] Definitive Chemoradiation Therapy for Advanced Oral Cavity Cancer: A 20-Year Experience
    Melotek, J. M.
    Brisson, R. J.
    Villaflor, V. M.
    Seiwert, T. Y.
    Cohen, E.
    Blair, E. A.
    Portugal, L.
    Stenson, K. M.
    Haraf, D. J.
    Vokes, E. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S84 - S84
  • [9] Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer:Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    Hyung-SikLee
    YoungminChoi
    Won-JooHur
    Hyo-JinKim
    Hyuk-ChanKwon
    Sung-HyunKim
    Jae-SeokKim
    Jong-Hoon Lee
    Ghap-JoongJung
    Min-ChanKim
    [J]. World Journal of Gastroenterology, 2006, (04) : 603 - 607
  • [10] Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    Lee, Hyung-Sik
    Choi, Youngmin
    Hur, Won-Joo
    Kim, Hyo-In
    Kwon, Hyuk-Chan
    Kim, Sung-Hyun
    Kim, Jae-Seok
    Lee, Jong-Hoon
    Jung, Ghap-Joong
    Kim, Min-Chan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (04) : 603 - 607
12345